Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Claudine Bruck currently holds 13,709 shares of NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Claudine Bruck has been a net buyer of NAVB stock. They have purchased $14.7K and sold $0 worth of shares.
Claudine Bruck's most recent insider trade was on Sep 10, 2025, when they sold 7,142 shares at $0.14 per share.
Claudine Bruck serves as Executive at NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB). They have executed 15 insider transactions totaling $14.7K over their tenure at the company.
Claudine Bruck holds the position of Executive at NAVIDEA BIOPHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Claudine Bruck has shown a buying trading pattern, with $14.7K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Claudine Bruck was on Apr 7, 2023, when they purchased $6.3K worth of ANVS shares. This transaction involved 500 shares at $12.61 per share.
Claudine Bruck currently owns 13,709 shares of NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Claudine Bruck's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Claudine Bruck has 15 Form 4 filings on record as an insider at NAVIDEA BIOPHARMACEUTICALS, INC..
Set alerts for Claudine Bruck and 40,000+ other insiders.